Feldene and Talwin 50 drug interactions - a phase IV clinical study of FDA data
Summary:
We study 3,918 people who take Feldene (piroxicam) and Talwin 50 (pentazocine hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Feldene and Talwin 50. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Feldene?
Feldene has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 3,913 Feldene users. Check the latest studies of Feldene.
What is Talwin 50?
Talwin 50 has active ingredients of pentazocine hydrochloride. eHealthMe is studying from 5 Talwin 50 users. Check the latest studies of Talwin 50.
No report is found.
Do you take Feldene and Talwin 50?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .
- Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on piroxicam and pentazocine hydrochloride (the active ingredients of Feldene and Talwin 50, respectively), and Feldene and Talwin 50 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Actrapid cause Bradycardia? - now
- Synovitis and drugs of ingredients of cetirizine hydrochloride - a second ago
- Could Acetaminophen And Hydrocodone Bitartrate cause Cachexia? - a second ago
- Drug interactions of Sertraline and Sovaldi - a second ago
- Adcirca and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Girls aged 10-19 - 4 seconds ago
- Adcirca and Weariness for Girls aged 10-19 - 5 seconds ago
- Adcirca and Tiredness for Girls aged 10-19 - 5 seconds ago
- Adcirca and Lethargy for Girls aged 10-19 - 5 seconds ago
- Could Tradjenta cause Ligament Sprain? - 5 seconds ago
- Adcirca and Exhaustion for Girls aged 10-19 - 6 seconds ago